Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy. [electronic resource]
Producer: 20101216Description: 225-9 p. digitalISSN:- 1563-258X
- Adalimumab
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Biological Products -- adverse effects
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Substitution
- Drug Therapy, Combination
- Drug Tolerance
- Etanercept
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Infusions, Intravenous
- Injections, Subcutaneous
- Interleukin 1 Receptor Antagonist Protein -- adverse effects
- Longitudinal Studies
- Receptors, Tumor Necrosis Factor -- antagonists & inhibitors
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.